Hengrui Liu

4.0k total citations · 1 hit paper
61 papers, 1.7k citations indexed

About

Hengrui Liu is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Hengrui Liu has authored 61 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 15 papers in Pulmonary and Respiratory Medicine and 11 papers in Cancer Research. Recurrent topics in Hengrui Liu's work include Ferroptosis and cancer prognosis (10 papers), Cancer, Stress, Anesthesia, and Immune Response (8 papers) and Anesthesia and Neurotoxicity Research (7 papers). Hengrui Liu is often cited by papers focused on Ferroptosis and cancer prognosis (10 papers), Cancer, Stress, Anesthesia, and Immune Response (8 papers) and Anesthesia and Neurotoxicity Research (7 papers). Hengrui Liu collaborates with scholars based in China, United States and United Kingdom. Hengrui Liu's co-authors include James P. Dilger, Jun Lin, Tao Tang, Ru Li, Li Yang, Xiaofeng Zhu, Chaopeng Wang, Panpan Wang, Yingquan Xiong and Ling Ou and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cancer Research.

In The Last Decade

Hengrui Liu

50 papers receiving 1.6k citations

Hit Papers

Identification of the novel exhausted T cell CD8 + marker... 2024 2026 2025 2024 10 20 30 40 50

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hengrui Liu China 27 782 445 305 286 205 61 1.7k
Lin Zhou China 25 832 1.1× 443 1.0× 634 2.1× 186 0.7× 120 0.6× 70 1.9k
Ying Shen China 30 1.0k 1.3× 355 0.8× 336 1.1× 295 1.0× 228 1.1× 129 2.4k
Jiguang Ma China 33 1.2k 1.6× 627 1.4× 120 0.4× 910 3.2× 230 1.1× 52 2.3k
Yong Yan China 26 821 1.0× 391 0.9× 220 0.7× 147 0.5× 109 0.5× 89 1.7k
Tongyan Liu China 18 851 1.1× 437 1.0× 195 0.6× 614 2.1× 348 1.7× 55 2.0k
Matthew L. Hemming United States 18 691 0.9× 158 0.4× 235 0.8× 242 0.8× 51 0.2× 25 1.6k
Nan Mu China 24 774 1.0× 320 0.7× 115 0.4× 183 0.6× 168 0.8× 55 1.5k
Keiko T. Kitazato Japan 30 566 0.7× 228 0.5× 462 1.5× 91 0.3× 407 2.0× 73 2.6k
Wook Jin South Korea 25 721 0.9× 358 0.8× 334 1.1× 504 1.8× 104 0.5× 55 1.8k

Countries citing papers authored by Hengrui Liu

Since Specialization
Citations

This map shows the geographic impact of Hengrui Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hengrui Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hengrui Liu more than expected).

Fields of papers citing papers by Hengrui Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hengrui Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hengrui Liu. The network helps show where Hengrui Liu may publish in the future.

Co-authorship network of co-authors of Hengrui Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Hengrui Liu. A scholar is included among the top collaborators of Hengrui Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hengrui Liu. Hengrui Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Hengrui, et al.. (2025). Single-cell and bulk RNA sequencing analysis reveals CENPA as a potential biomarker and therapeutic target in cancers. PLoS ONE. 20(1). e0314745–e0314745. 8 indexed citations
2.
Liu, Hengrui, Samir W. Hamaia, Fernando Hernández, et al.. (2025). The voltage-gated sodium channel β3 subunit modulates C6 glioma cell motility independently of channel activity. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1871(6). 167844–167844. 8 indexed citations
3.
Guo, Zheng, Yulu Zheng, Ya-Hong Zhu, et al.. (2025). Restricted Social Engagement Is Associated With Depressive Symptoms in Older Chinese Adults: A Nationwide Cross‐Sectional Study. Health Science Reports. 8(9). e71262–e71262.
4.
Liu, Hengrui, et al.. (2025). Bridging Discovery and Treatment: Cancer Biomarker. Cancers. 17(22). 3720–3720.
5.
Chen, Tingting, Xiaoqin Wu, Danna Wang, et al.. (2025). Exocarpium Citri Grandis Ameliorates Metabolic Disorders by Inhibiting Inflammatory Responses and NLRP3 Inflammasome Activation. Food Science & Nutrition. 13(11). e71074–e71074.
6.
Wang, Jiayu, Zhiqiang Chen, Wangrui Liu, et al.. (2025). Harnessing plant-derived natural compounds to target ferroptosis, pyroptosis, immune modulation and renin-angiotensin system in renal cell carcinoma. Journal of the Renin-Angiotensin-Aldosterone System. 26.
7.
Ou, Ling, Hengrui Liu, Zhixiang Zhu, et al.. (2025). In vitro antibacterial activity of neochebulinic acid from aqueous extract of Terminalia chebula Retz against Helicobacter pylori. BMC Complementary Medicine and Therapies. 25(1). 287–287. 1 indexed citations
8.
Liu, Hengrui, Zheng Guo, & Panpan Wang. (2024). Genetic expression in cancer research: Challenges and complexity. Gene Reports. 37. 102042–102042. 38 indexed citations
9.
Beaudoin, Christopher A., Samantha C. Salvage, Hengrui Liu, et al.. (2024). Isoform-specific N-linked glycosylation of NaV channel α-subunits alters β-subunit binding sites. The Journal of General Physiology. 157(1).
10.
Ou, Ling, Hengrui Liu, Zhixiang Zhu, et al.. (2024). Chebulinic acid isolated from aqueous extracts of Terminalia chebula Retz inhibits Helicobacter pylori infection by potential binding to Cag A protein and regulating adhesion. Frontiers in Microbiology. 15. 1416794–1416794. 15 indexed citations
11.
Ou, Ling, Zhixiang Zhu, Qingwei Li, et al.. (2024). 1,3,6-Trigalloylglucose: A Novel Potent Anti-Helicobacter pylori Adhesion Agent Derived from Aqueous Extracts of Terminalia chebula Retz. Molecules. 29(5). 1161–1161. 16 indexed citations
12.
Liu, Hengrui, et al.. (2024). Identification of the novel exhausted T cell CD8 + markers in breast cancer. Scientific Reports. 14(1). 19142–19142. 56 indexed citations breakdown →
14.
Ou, Ling, Hengrui Liu, Xiaoyan Shi, et al.. (2023). Terminalia chebula Retz. aqueous extract inhibits the Helicobacter pylori-induced inflammatory response by regulating the inflammasome signaling and ER-stress pathway. Journal of Ethnopharmacology. 320. 117428–117428. 21 indexed citations
15.
Peng, Chang, Zhong Feng, Ling Ou, et al.. (2023). Syzygium aromaticum enhances innate immunity by triggering macrophage M1 polarization and alleviates Helicobacter pylori-induced inflammation. Journal of Functional Foods. 107. 105626–105626. 22 indexed citations
16.
Liu, Hengrui, James P. Dilger, & Jun Lin. (2021). Lidocaine Suppresses Viability and Migration of Human Breast Cancer Cells: TRPM7 as a Target for Some Breast Cancer Cell Lines. Cancers. 13(2). 234–234. 54 indexed citations
18.
Liu, Hengrui, Yingquan Xiong, Haixia Wang, et al.. (2018). Effects of water extract from epimedium on neuropeptide signaling in an ovariectomized osteoporosis rat model. Journal of Ethnopharmacology. 221. 126–136. 64 indexed citations
19.
Wang, Chaopeng, Jiefang Wang, Hengrui Liu, et al.. (2016). Effect of Herba Epimedium Extract on Bone Mineral Density and Microstructure in Ovariectomised Rat. Journal of Pharmaceutical and Biomedical Sciences. 6(5). 4 indexed citations
20.
Chen, Guangming, Chaopeng Wang, Jiefang Wang, et al.. (2016). Antiosteoporotic effect of icariin in ovariectomized rats is mediated via the Wnt/β-catenin pathway. Experimental and Therapeutic Medicine. 12(1). 279–287. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026